Prostatis Group’s Danaher DHR Stock Holding History

Prostatis Group’s Portfolio DHR Stock Details DHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-45,869	Closed	-$45.2K	–	131
2023 Q2	$45.2K	Buy	+45,869	New	+$9.71M	0.02%	185

Other funds holding DHR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Prostatis Group's DHR Position: Q3 2023 in Review

Prostatis Group sold out of Danaher (DHR) in Q3 2023, closing a stake of 45,869 shares — an estimated $45.2K sold.

Prostatis Group first reported a position in DHR in Q2 2023 and held it in 1 quarter. The position peaked at $45.2K in Q2 2023. 2,087 funds tracked by Wall St. Rank hold DHR as of Q3 2023.

Prostatis Group reported no remaining Danaher position as of Q3 2023 after selling out during the quarter.
Prostatis Group sold 45,869 Danaher shares in Q3 2023, an estimated $45.2K.
Prostatis Group first reported a position in Danaher in Q2 2023 and held it in 1 quarter.
Prostatis Group's Danaher position peaked at $45.2K in Q2 2023.
2,087 funds tracked by Wall St. Rank held Danaher as of Q3 2023.

Based on Prostatis Group's 13F filing for Q3 2023, filed 21 Mar 2025.